NCT04160832View on ClinicalTrials.gov

Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 24, 2019

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Colorectal Neoplasm
Interventions
GENETIC

Multi-Cancer Cancer Panel

Eligible patients will receive genetic testing to determine germline cancer predisposition.

Trial Locations (1)

80045

University of Colorado Denver, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT04160832 - Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps | Biotech Hunter | Biotech Hunter